If you’re an adult with liver disease that may call for a transplant, your MELD score helps to tell how quickly you might need it. A MELD score is a number that ranges from 6 to 40, based on lab tests ...
End-stage liver disease patients at lower risk for death in the short term still reaped the substantial benefits of a living-donor liver transplant (LDLT), a case-control study revealed. Compared with ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Patient survival was no different for living donor liver transplant recipients with a MELD score ...
Please provide your email address to receive an email when new articles are posted on . On-treatment improvement of MELD scores correlated with reduced risk for all-cause mortality and hepatic events ...
Since its proposal, the Model for End-Stage Liver Disease (MELD) score has been employed to predict short-term mortality among patients with chronic liver disease and those awaiting liver ...
During the 3-month follow up, 223 patients died. The causes of death were all related to liver disease: 49 patients died of hepatorenal syndrome; 117 patients died of hepatic encephlophy; 44 patients ...
Prognostic scores are valuable tools for predicting survival in patients with chronic liver disease. Recently, the albumin-bilirubin (ALBI) score has emerged as a potential prognostic indicator in ...
Adoption of a new version of the Model for End-Stage Liver Disease, known as MELD 3.0, closed the gap in access to liver transplant between men and women, an analysis showed. Since MELD 3.0 was ...
Liver transplant candidates may get a fairer shake from an artificial intelligence-based organ allocation system than that offered by the current Model for End-Stage Liver Disease (MELD) scoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results